| Clinical Diagnosis | Count |
|---|---|
| Arthralgia | 33,837 |
| Lymphadenopathy | 18,560 |
| Tinnitus | 6,790 |
| Syncope | 5,373 |
| COVID-19¹ | 4,087 |
| Vertigo | 3,945 |
| Epistaxis | 3,366 |
| Shingles (Herpes Zoster) | 3,278 |
| Seizures | 2,131 |
| Premature Deaths | 1,945 |
| Hypertension (High Blood Pressure) | 1,794 |
| Myocarditis/ Pericarditis | 1,633 |
| Anaphylaxis³ | 1,522 |
| Thrombocytopenia/ Platelet Deficiency² | 1,487 |
| Bell’s Palsy | 1,252 |
| Heart Attacks/ Cardiac Arrest⁴ | 1,195 |
| Hypotension (Low Blood Pressure) | 1,018 |
| Neoplasms⁵ | 867 |
| Miscarriages⁶ | 703 |
| Guillain-Barré Syndrome (GBS) | 584 |
| Paralysis | 510 |
| Sepsis | 186 |
| Lupus⁷ | 69 |
| Stillbirth/ Fetal Death | 19 |
| Lyme Disease | 12 |
| AIDS | 3 |
| SOC TOTAL | 1,337,933 |
| Clinical Diagnosis | Count |
|---|---|
| Permanent Disability | 44,512 |
| Severe Allergy | 40,123 |
| Myocarditis/ Pericarditis | 34,448 |
| Thromboses (Blood Clots)/ Strokes¹ | 31,727 |
| Syncope | 29,133 |
| Premature Deaths | 24,402 |
| Tinnitus | 19,045 |
| Bell’s Palsy | 14,157 |
| Vertigo | 13,039 |
| Shingles (Herpes Zoster) | 12,566 |
| Heart Attacks/ Cardiac Arrest | 12,511 |
| Anaphylaxis | 9,262 |
| Infarction² | 9,191 |
| Thrombocytopenia/ Platelet Deficiency | 5,725 |
| Miscarriages | 4,142 |
| Permanent Hearing Loss | 2,552 |
| Sepsis | 1,832 |
| Cancer³ | 703 |
| Lupus⁴ | 433 |
| Lyme Disease | 326 |
| Amputations | 64 |
| AIDS | 6 |
| TOTAL | 1,134,982 |
| Adverse Reaction | MedAlerts.org | OpenVAERS |
|---|---|---|
| Anaphylaxis | 42,265 | 9,262 |
| Bell’s Palsy | 9,006 | 14,157 |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| CSL Limited* | 1 | 0.002% |
| Dynavax Technologies Corporation | 1 | 0.002% |
| GlaxoSmithKline Biologicals | 32 | 0.08% |
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 1,954 | 4.62% |
| MedImmune Vaccines, Inc.** | 2 | 0.005% |
| Merck & Co. Inc. | 8 | 0.02% |
| Moderna Therapeutics | 17,009 | 40.24% |
| Novartis Vaccines and Diagnostics | 1 | 0.002% |
| Pfizer/ BioNTech | 24,219 | 57.3% |
| Protein Sciences Corporation*** | 5 | 0.01% |
| Sanofi Pasteur/ Translate Bio | 26 | 0.06% |
| Seqirus, Inc.**** | 37 | 0.09% |
| Teva Pharmaceuticals USA, Inc.***** | 1 | 0.002% |
| Undisclosed Manufacturers | 342 | 0.81% |
| TOTAL | †43,638 | †103.25% |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| CSL Limited | 1 | 0.04% |
| GlaxoSmithKline Biologicals | 5 | 0.22% |
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 442 | 19.1% |
| Merck & Co., Inc. | 1 | 0.04% |
| Moderna Therapeutics | 447 | 19.32% |
| Pfizer/ BioNTech | 1,481 | 64% |
| Sanofi Pasteur/ Translate Bio | 4 | 0.17% |
| Seqirus, Inc. | 1 | 0.04% |
| Undisclosed Manufacturers | 33 | 1.43% |
| TOTAL | †2,415 | †104.36% |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| GlaxoSmithKline Biologicals | 5 | 0.06% |
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 469 | 5.21% |
| Merck & Co. Inc. | 4 | 0.04% |
| Moderna Therapeutics | 1,957 | 21.73% |
| Novartis Vaccines and Diagnostics | 2 | 0.02% |
| Pfizer/ BioNTech | 6,808 | 75.59% |
| Protein Sciences Corporation | 1 | 0.01% |
| Sanofi Pasteur/ Translate Bio | 4 | 0.04% |
| Seqirus, Inc. | 3 | 0.03% |
| Undisclosed Manufacturers | 71 | 0.79% |
| TOTAL | †9,324 | †103.53% |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 174 | 9.46% |
| Merck & Co. Inc. | 1 | 0.05% |
| Moderna Therapeutics | 474 | 25.76% |
| Pfizer/ BioNTech | 1,239 | 67.34% |
| Sanofi Pasteur/ Translate Bio | 1 | 0.05% |
| Seqirus, Inc. | 2 | 0.11% |
| Undisclosed Manufacturers | 18 | 0.98% |
| TOTAL | †1,909 | †103.75% |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| GlaxoSmithKline Biologicals | 3 | 0.17% |
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 176 | 9.84% |
| Merck & Co. Inc. | 4 | 0.22% |
| Moderna Therapeutics | 435 | 24.32% |
| Novartis Vaccines and Diagnostics | 1 | 0.06% |
| Pfizer/ BioNTech | 1,215 | 67.92% |
| Sanofi Pasteur/ Translate Bio | 2 | 0.11% |
| Seqirus, Inc. | 1 | 0.06% |
| Undisclosed Manufacturers | 18 | 1.01% |
| TOTAL | †1,855 | †103.69% |
| Vaccine Manufacturer | Count | Percentageᴬ |
|---|---|---|
| CSL Limited | 1 | 0.004% |
| GlaxoSmithKline Biologicals | 10 | 0.04% |
| Johnson & Johnson (Janssen Pharmaceutical Companies) | 2,188 | 8.97% |
| MedImmune Vaccines, Inc. | 1 | 0.004% |
| Merck & Co., Inc. | 1 | 0.004% |
| Moderna Therapeutics | 6,936 | 28.42% |
| Novartis Vaccines and Diagnostics | 5 | 0.02% |
| Pfizer/ BioNTech | 17,245 | 70.67% |
| Protein Sciences Corporation | 1 | 0.004% |
| Sanofi Pasteur/ Translate Bio | 17 | 0.07% |
| Seqirus, Inc. | 6 | 0.02% |
| Undisclosed Manufacturers | 388 | 1.59% |
| TOTAL | †26,799 | †109.82% |
| Chronological Age | Count | Percentage |
|---|---|---|
| Under 3 Years | 4 | 0.02% |
| 3-6 Years | 1 | 0.004% |
| 6-9 Years | 2 | 0.008% |
| 9-12 Years | 1 | 0.004% |
| 12-17 Years | 59 | 0.24% |
| 17-44 Years | 968 | 3.97% |
| 44-65 Years | 2,962 | 12.14% |
| 65-75 Years | 3,460 | 14.18% |
| 75+ Years | 7,687 | 31.5% |
| Undisclosed | 9,258 | 37.94% |
| TOTAL | 24,402 | 100% |
just want to enter my own question or poll:
ReplyDeletedoes anyone actually believe that man, living in a 3D limited physicality dimension, can actually cause an "extinction level event"? please. we don't understand all the properties of the local galaxy OR the different dimensions, factors, and beings involved with earth, whom herself is a LIVING CONSCIOUSNESS. SHE makes the rules...not man.
Hello, and thank you for your input with regard to this particular topic of discussion, you present an interesting argument in that - and, correct me if my assumption is a presumptive form of conjecture - the Earth itself exhibits a certain degree of 'sentient' capacity. Similar in context to what is oftentimes postulated by members of the scientific community - the majority of whom have been ostracized by their contemporaries in their respective disciplines - regarding the existence of what has come to be known colloquially as a train of thought closely related to the 'Gaia Paradigm.' Theoretical discourse referencing the confluence of human-based interaction at the most fundamental level of its existence that functions as the operant extension of the system's continuum, where the Earth itself is recognized as a celestial entity possessing self-regulatory capability. Would this assertion be an accurate reflection of your reasoning?
Delete